Upgrade to SI Premium - Free Trial

Arcutis Biotherapeutics (ARQT)

26.58 +2.09 (8.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Arcutis presents Zoryve and corticosteroid data at dermatology meetings October 9, 2026 8:01 AM - StreetInsider Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical October 9, 2026 8:00 AM - StreetInsider Jefferies Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT) ahead of earnings October 8, 2026 4:23 AM - StreetInsider Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award October 6, 2026 8:19 AM - Globe NewsWire Form SCHEDULE 13G/A Arcutis Biotherapeutics, Filed by: BlackRock, Inc. October 5, 2026 11:59 AM - SEC Filing Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 2, 2026 4:00 PM - Globe NewsWire Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options September 29, 2026 9:15 AM - StreetInsider Form 4 Arcutis Biotherapeutics, For: Sep 16 Filed by: Matsuda Masaru September 18, 2026 4:17 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Sep 15 Filed by: Welgus Howard G. September 17, 2026 4:07 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Edwards Larry Todd September 16, 2026 4:08 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Welgus Howard G. September 15, 2026 4:04 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Sep 08 Filed by: Matsuda Masaru September 10, 2026 7:25 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 27 Filed by: Curran Terrie August 28, 2026 5:40 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Curran Terrie August 27, 2026 4:06 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 20 Filed by: Curran Terrie August 24, 2026 4:20 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 19 Filed by: Burnett Patrick August 21, 2026 4:08 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Curran Terrie August 20, 2026 4:51 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 17 Filed by: Welgus Howard G. August 19, 2026 4:57 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Burnett Patrick August 19, 2026 4:27 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Welgus Howard G. August 17, 2026 4:28 PM - SEC Filing Form SCHEDULE 13G Arcutis Biotherapeutics, Filed by: Polar Capital Holdings Plc August 14, 2026 6:21 AM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 11 Filed by: Burnett Patrick August 13, 2026 8:07 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Burnett Patrick August 11, 2026 5:16 PM - SEC Filing Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 7, 2026 4:00 PM - Globe NewsWire Form SCHEDULE 13G Arcutis Biotherapeutics, Filed by: STATE STREET CORP August 7, 2026 8:57 AM - SEC Filing Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $40 at Needham August 6, 2026 7:14 AM - StreetInsider Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $36 at Mizuho August 6, 2026 6:51 AM - StreetInsider Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $38 at Guggenheim August 6, 2026 6:44 AM - StreetInsider Arcutis Biotherapeutics, Inc. (ARQT) Tops Q2 EPS by 7c ; Offers Guidance August 6, 2026 12:56 AM - StreetInsider Form 4 Arcutis Biotherapeutics, For: Aug 03 Filed by: Burnett Patrick August 5, 2026 9:42 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 03 Filed by: Matsuda Masaru August 5, 2026 9:42 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Aug 03 Filed by: Watanabe Todd August 5, 2026 9:42 PM - SEC Filing Form 10-Q Arcutis Biotherapeutics, For: Jun 30 August 5, 2026 4:26 PM - SEC Filing Form 8-K Arcutis Biotherapeutics, For: Jul 31 August 5, 2026 4:18 PM - SEC Filing Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update August 5, 2026 4:00 PM - StreetInsider Form 144 Arcutis Biotherapeutics, Filed by: Matsuda Masaru August 3, 2026 5:08 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Watanabe Todd August 3, 2026 5:07 PM - SEC Filing Form 144 Arcutis Biotherapeutics, Filed by: Burnett Patrick August 3, 2026 5:07 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Jul 15 Filed by: Peetz Christopher July 17, 2026 4:07 PM - SEC Filing Form 3 Arcutis Biotherapeutics, For: Jul 15 Filed by: Peetz Christopher July 17, 2026 4:05 PM - SEC Filing Form 4 Arcutis Biotherapeutics, For: Jul 15 Filed by: Welgus Howard G. July 17, 2026 4:01 PM - SEC Filing Form 8-K Arcutis Biotherapeutics, For: Jul 15 July 16, 2026 4:25 PM - SEC Filing Arcutis adds Mirum Pharmaceuticals CEO Chris Peetz to its board July 16, 2026 9:00 AM - StreetInsider Arcutis Expands Board of Directors with Appointment of Chris Peetz July 16, 2026 9:00 AM - StreetInsider Form 144 Arcutis Biotherapeutics, Filed by: Welgus Howard G. July 15, 2026 4:02 PM - SEC Filing Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026 July 15, 2026 4:00 PM - Globe NewsWire Attovia Therapeutics names John Smither to board of directors July 15, 2026 8:30 AM - StreetInsider Attovia Therapeutics Appoints John W. Smither to Board of Directors July 15, 2026 8:30 AM - Globe NewsWire Full Article List